Patents by Inventor Michael Durben

Michael Durben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC ANTIBODY MOLECULE
    Publication number: 20180057608
    Abstract: The present invention relates to a method of treating a disease. The method comprises administering to a patient in need thereof a recombinant bispecific antibody molecule consisting of a Fab fragment comprising a first binding site for a first antigen, a single chain Fv fragment comprising a second binding site for a second antigen and an immunoglobulin IgG1 CH2 domain.
    Type: Application
    Filed: June 27, 2017
    Publication date: March 1, 2018
    Inventors: Gundram Jung, Michael DURBEN, Ludger Grosse-Hovest
  • Bispecific antibody molecule
    Patent number: 9718893
    Abstract: The present invention relates to a bispecific antibody molecule, as well as a method for producing the same, its use and a nucleic acid molecule encoding the bispecific antibody molecule. The invention in particular provides an antibody molecule that is capable of mediating target cell restricted activation of immune cells.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: August 1, 2017
    Assignee: SYNIMMUNE GMBH
    Inventors: Gundram Jung, Michael Durben, Ludger Grosse-Hovest
  • BISPECIFIC ANTIBODY MOLECULE
    Publication number: 20150119555
    Abstract: The present invention relates to a bispecific antibody molecule, as well as a method for producing the same, its use and a nucleic acid molecule encoding the bispecific antibody molecule. The invention in particular provides an antibody molecule that is capable of mediating target cell restricted activation of immune cells.
    Type: Application
    Filed: November 12, 2012
    Publication date: April 30, 2015
    Applicant: SYNIMMUNE GMBH
    Inventors: Gundram Jung, Michael Durben, Ludger Grosse-Hovest